Proteins and Peptides

31 Mar 2007 RegeneRx Files IND to Begin Phase 2 Ophthalmic Clinical Trial
31 Mar 2007 Baxter Announces FDA Approval of CEPROTIN for Severe Congenital Protein C Deficiency
30 Mar 2007 Proteo, Inc./Proteo Biotech AG: European Commission grants Orphan Drug Status to Elafin for the treatment of PAH
30 Mar 2007 Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery of GLP-1 and PYY
30 Mar 2007 Gloucester Pharmaceuticals' Development of Romidepsin for Cutaneous T-Cell Lymphoma Continues Following Planned Review by Data Safety Monitoring Board
30 Mar 2007 Pieris Demonstrates Potent Anti-Tumor Activity of a VEGF-Specific Anticalin(R) in Preclinical Studies
29 Mar 2007 Protox Initiates Phase I Study of PRX302 for Benign Prostatic Hyperplasia
28 Mar 2007 CoGenesys, Inc. Expands Clinical Programs with Initiation of Phase 1-2a Trial of Neugranin in Cancer Patients
27 Mar 2007 Novartis to launch its own branded version of a leading multiple sclerosis therapy through agreement with Bayer Schering Pharma
27 Mar 2007 Wyeth Receives FDA Approval for New BeneFIX Features That Provide Hemophilia B Patients a Simpler and More Convenient Preparation Process for Recombinant Factor IX
27 Mar 2007 CSL Therapy That Mimics 'Good' Cholesterol May Reduce Plaque Volume in Coronary Arteries
27 Mar 2007 ACUITY One-Year Findings Meet All Primary Endpoints in Favor of Angiomax(R) (Bivalirudin) Alone Treatment Group
26 Mar 2007 Scios Announces Results From Exploratory Nesiritide Study Providing Important New Renal and Mortality Safety Data with a Neutral Effect on the Primary Endpoint
23 Mar 2007 Æterna Zentaris Reports Positive Results with Cetrorelix in BPH for Japanese Phase 2a Trial
22 Mar 2007 BioGeneriX and Neose Announce Initiation of 2nd Phase I Clinical Trial of GlycoPEG-GCSF; Interim Results From 1st Phase I Trial Show Dose-Dependent Response
22 Mar 2007 BioLineRx In-Licenses Novel Peptide for the Treatment of Inflammatory Diseases
21 Mar 2007 Talecris Initiates Clinical Development Program Evaluating Plasmin for Dissolving Blood Clots and Restoring Blood Flow in Legs
21 Mar 2007 Radius Begins Phase II Clinical Trial of BA058 for Osteoporosis
21 Mar 2007 Potentia Pharmaceuticals Announces Initiation of Phase I Clinical Trials to Evaluate its Lead Compound for Age-Related Macular Degeneration
16 Mar 2007 Affibody to publish data on therapeutic effects of Affibody(R) molecules in a cancer model
16 Mar 2007 Aida Pharmaceuticals Initiates Preclinical Research of Potential Anti-Cancer Treatment Vasostatin-Apo2L
16 Mar 2007 Neose Receives FDA Clearance to Commence U.S. Clinical Trials for NE-180
16 Mar 2007 Pacgen completes patient recruitment for Phase I/II trial of novel anti-fungal drug
15 Mar 2007 Lev Pharmaceuticals, Inc. Reports Positive Results in Pivotal Phase III Trial for Hereditary Angioedema
14 Mar 2007 Ambrilia and Mallinckrodt Announce IND Filing for Phase III Clinical Study of Improved Octreotide Formulation

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up